伪装成原发性腹腔内肿瘤的肝脏原发性胃肠道间质瘤：一种罕见的肝脏胃肠道外间质瘤（EGIST） - Suppr | 超能文献

相似文献

1

Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver.伪装成原发性腹腔内肿瘤的肝脏原发性胃肠道间质瘤：一种罕见的肝脏胃肠道外间质瘤（EGIST）

J Gastrointest Cancer. 2014 Sep;45(3):392-4. doi: 10.1007/s12029-013-9514-6.

2

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.多模态功能成像用于伊马替尼治疗的胃肠道间质瘤患者的早期反应评估

Acta Oncol. 2014 Jan;53(1):143-8. doi: 10.3109/0284186X.2013.798428. Epub 2013 May 28.

3

Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate).

Front Biosci. 2006 Jan 1;11:498-501. doi: 10.2741/1813.

4

[Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].两例复发性胃肠道间质瘤患者采用每日100毫克甲磺酸伊马替尼成功治疗

Gan To Kagaku Ryoho. 2013 Jun;40(6):803-5.

5

CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy.在评估接受伊马替尼治疗的胃肠道肿瘤（GIST）患者时，CT扫描并非万能。

Pathol Oncol Res. 2012 Oct;18(4):1095-7. doi: 10.1007/s12253-011-9445-0. Epub 2011 Sep 17.

6

Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.18F-FDG PET/CT 评估伊马替尼（格列卫）治疗胃肠道间质瘤（GIST）的延伸模式。

Rev Esp Enferm Dig. 2012 Jul;104(7):360-6. doi: 10.4321/s1130-01082012000700005.

7

Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients.伊马替尼血药浓度监测指导下剂量调整用于胃肠间质瘤患者伊马替尼相关毒性管理。

J Korean Med Sci. 2013 Aug;28(8):1248-52. doi: 10.3346/jkms.2013.28.8.1248. Epub 2013 Jul 31.

8

[A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].[一例使用伊马替尼治疗的胃肠道间质瘤肝骨转移病例]

Gan To Kagaku Ryoho. 2014 Jan;41(1):99-101.

9

The radiology of gastrointestinal stromal tumours (GIST).胃肠道间质瘤（GIST）的放射学

Cancer Imaging. 2005 Dec 15;5(1):150-6. doi: 10.1102/1470-7330.2005.0109.

10

[Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].[继发性伊马替尼耐药胃肠道间质瘤的分子与组织学特征]

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):42-3. doi: 10.3760/cma.j.issn.0529-5807.2013.01.009.

引用本文的文献

1

An update on gastrointestinal stromal tumors (GISTs) with a focus on extragastrointestinal stromal tumors (EGISTs).胃肠道间质瘤（GISTs）的最新进展，重点关注胃肠道外间质瘤（EGISTs）。

Gastroenterol Rep (Oxf). 2025 Jul 23;13:goaf068. doi: 10.1093/gastro/goaf068. eCollection 2025.

2

Case report: 10-year survival of a patient with a primary hepatic gastrointestinal stromal tumor.病例报告：一名原发性肝胃肠间质瘤患者的10年生存期

Front Oncol. 2022 Dec 1;12:1035824. doi: 10.3389/fonc.2022.1035824. eCollection 2022.

3

A case of primary hepatic stromal tumour misdiagnosed as a liver cyst.

本文引用的文献

1

Extragastrointestinal stromal tumors (EGIST): a series of case reports.胃肠道外间质瘤（EGIST）：一系列病例报告

Hepatogastroenterology. 2011 May-Jun;58(107-108):865-8.

2

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.表现为网膜肿块的胃肠道间质瘤——95例临床病理分析

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

3

Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours.